Watch Kids v Cancer’s Executive Director Nancy Goodman speak about the need to lower kids’ age of eligibility for clinical trials. more→
KIDS' ELIGIBILITY FOR TRIALS NEWS
Cancer researchers push to relax rules for clinical trials (Nature)
US government examines whether criteria for participating in clinical trials unnecessarily exclude some patients, including children. more→
Modernizing clinical trial eligibility: Recommendations of the ASCO–FCR Minimum Age Working Group (Journal of Clinical Oncology)
Including children in adult clinical oncology trials is feasible and can be done without compromising safety, concludes a study co-authored by KVC’s Nancy Goodman. more→
Broadening eligibility criteria for clinical oncology trials (Journal of Clinical Oncology)
ASCO-Friends of Cancer Research working group examines specific eligibility criteria to determine whether to modify definitions to extend clinical trials to a broader population. more→
Approvals in 2016: the march of the checkpoint inhibitors (Nature Reviews)
The FDA pledges to continue to support the expansion of patient eligibility criteria in oncology clinical trials, improving generalizability and access to trials while ensuring patient safety. more→
Enrolling adolescents in disease/target-appropriate adult oncology clinical trials of investigational agents (Clinical Cancer Research)
The paper recommends the inclusion of adolescents (ages 12-17) in disease- and target-appropriate adult oncology trials. more→
Too many PD-1 trials for adults, too few for children (The Cancer Letter, by Nancy Goodman)
Why are there so few trials for which children and young teens would qualify? Shouldn’t kids and teens also get a shot at exciting investigational drugs? more→